Literature DB >> 17688010

Clozapine-induced seizures: recognition and treatment.

Jason Wong1, Nicholas Delva.   

Abstract

OBJECTIVES: To inform clinicians about the types of seizures that can be induced by clozapine and to provide recommendations for treatment.
METHODS: We identified articles on clozapine-induced seizures from a MEDLINE search of the English-language literature from 1978 to July 2006. The frequency of each type of seizure and the dosages of clozapine associated with seizures were compiled. In addition to this review, we report a new case illustrating the challenge of diagnosing subtle seizure activity.
RESULTS: The tonic-clonic variety is the most frequently described clozapine-induced seizure. Myoclonic and atonic seizures together constitute about one-quarter of the reported seizures. The mean dosage of clozapine associated with seizures is not high (less than 600 mg daily).
CONCLUSIONS: It may be difficult for clinicians to recognize subtle types of clozapine-induced seizures, such as myoclonic, atonic, or partial seizures. Clinicians should not place excessive reliance on the plasma level of clozapine or electroencephalogram findings to predict the occurrence of seizures. When a first seizure occurs, it is recommended that the dosage of clozapine be reduced or an alternative antipsychotic agent be employed. If a second seizure occurs, an anticonvulsant drug should be started. Special attention should be paid when commencing or discontinuing concurrent medication that may affect the plasma level of clozapine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688010     DOI: 10.1177/070674370705200708

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  18 in total

1.  Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.

Authors:  Marie Humbert-Claude; Elisabeth Davenas; Florence Gbahou; Ludwig Vincent; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2011-09-13       Impact factor: 4.530

Review 2.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

3.  New Schizophrenia Treatments Address Unmet Clinical Needs.

Authors:  Chris Fellner
Journal:  P T       Date:  2017-02

4.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

5.  Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro.

Authors:  S D Greenhill; R S G Jones
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

6.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors:  Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

Review 7.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

Review 8.  Clozapine-induced myoclonus: a case report and review of the literature.

Authors:  Ian J Osborne; Ronan J McIvor
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

9.  Retrospective Review of Clozapine Use in Children and Adolescents.

Authors:  Ardelle Komaryk; Dean Elbe; Leah Burgess
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-02-01

10.  Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study.

Authors:  Nishant Goyal; Samir Kumar Praharaj; Pushpal Desarkar; Haque Nizamie
Journal:  Psychiatry Investig       Date:  2011-12-08       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.